Related references
Note: Only part of the references are listed.Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK
Michel Doumith et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Ertapenem Resistance among Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae Isolates
Azita Leavitt et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae
David Landman et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2009)
Reduced susceptibility to carbapenems in Klebsiella pneumoniae clinical isolates associated with plasmid-mediated beta-lactamase production and OmpK36 porin deficiency
Xuan Ding Wang et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2009)
Ertapenem or ticarcillin/clavulanate for the treatment of intra-abdominal infections or acute pelvic infections in pediatric patients
Albert E. Yellin et al.
AMERICAN JOURNAL OF SURGERY (2007)
In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum beta-lactamase
E Elliott et al.
CLINICAL INFECTIOUS DISEASES (2006)
Acquisition of resistant bowel flora during a double-blind randomized clinical trial of ertapenem versus piperacillin-tazobactam therapy for intraabdominal infections
MJ DiNubile et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
High levels of antimicrobial coresistance among extended-spectrum-β-lactamase-producing Enterobacteriaceae
MJ Schwaber et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Ertapenem, the first of a new group of carbapenems
PM Shah et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Properties and potential of ertapenem
DM Livermore et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections - Results of a double-blind, randomized comparative phase III trial
JS Solomkin et al.
ANNALS OF SURGERY (2003)
Ertapenem monotherapy versus combination therapy with ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections in adults
AE Yellin et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2002)
Share Paper
